Philip Wang

Chief Science Officer at Cambridge Health Alliance

Philip Wang, MD, DrPH, arrived at CHA in September 2019 as the health system's chief of psychiatry. In May 2022, he was named chief science officer and will support ongoing research efforts and scholarship within the organization.

Dr. Wang previously served as the deputy medical director and director of research of the American Psychiatric Association. In this role, he was responsible for developing and expanding practice resources for the more than 37,000 psychiatrists of the association. Preceding this position, Dr. Wang was the deputy director of the National Institute of Mental Health (NIMH). There, he assisted in overseeing 1,300 NIMH staff and approximately $1.5 billion spent annually on basic, translational and clinical research focused on prevention, recovery and cures.

Dr. Wang currently serves as professor of the practice in the Department of Psychiatry at Harvard Medical School. He has authored publications in leading medical journals and conducted national and global psychiatric epidemiology studies and pharmacoepidemiologic research as well as clinical trials to test new interventions. Dr. Wang was a member of the APA DSM-V Task Force and has consulted on several APA Work Groups that developed evidence-based treatment guidelines.

Dr. Wang completed his undergraduate degree in biochemistry, medical school, psychiatry residency and chief residency, as well as a master's and doctoral degree in epidemiology, at Harvard.

Timeline

  • Chief Science Officer

    Current role

View in org chart